Search
for

    GlossaryBinding Proteins

    molecules that attach to specific substances for transport or regulation

    Binding proteins are molecules that attach to specific substances, such as hormones, nutrients, or DNA, to help transport, stabilize, or regulate them within the body. For example, in the context of hair biology, certain binding proteins might interact with hormones like androgens, influencing hair growth and potentially playing a role in conditions like alopecia.

    Related Terms

    Learn

    5 / 5 results

      learn Cyproterone

      a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor

      learn Bicalutamide

      a nonsteroidal anti-androgen, most commonly used orally for women

      learn Estradiol

      an estrogen promoting hair regrowth more commonly used in women

      learn GT20029

      research compound made to degrade androgen receptors in scalp

    Research

    5 / 1000+ results

    Community Join

    5 / 380 results

      community CB-03-01 supposed hair loss cure

      in Treatment  8 upvotes 3 years ago
      The conversation discusses why CB-03-01, a potential hair loss treatment, isn't widely discussed despite evidence of its effectiveness and safety. Some users mention other treatments like melatonin, procianidin b2, and RU58841, debating their effectiveness and safety.

      community This serum outperformed Minoxidil in a recent study. Please debunk

       23 upvotes 5 years ago
      A topical solution called "Multi-Peptide Serum for Hair Density" by The Ordinary Company, which contains several ingredients that are used in alternatives to Minoxidil and was found to have better results than 5% Minoxidil in a study. People who have tried it shared their experiences with the serum as well.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 8 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.